Recently AstraZeneca and Merck & Co., Inc., known as MSD outside the US and Canada, today announced positive high-level results from the PROpel Phase III…
A medical oncologist from Tulane University co-led the VISION trial, a study focusing on the use of a specific engineered radioactive molecule used to target…
A group of oncology-focused researchers led by co-principal investigator Ashesh B. Jani, MD, professor of radiation oncology at Winship Cancer Institute at Emory University, revealed…
A world-renowned U.S. cancer research center and National Cancer Institute comprehensive cancer center based in the Los Angeles area has launched a Phase 2 clinical…
Pfizer’s Global Medical Grants group awarded a $250,000 grant to the prominent health system in the Detroit metropolitan area, Henry Ford Cancer Institute, to reduce…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
